N05: Patient involvement in inflammatory bowel disease therapy and disease-related parameters - is there an association?ECCO'22Year: 2022
Authors: Haj Natour, O.(1);Magnezi, R.(2);Ben Horin, S.(3);Lipkin, M.(3);Ungar, B.(3);Galper, A.(3);Sina, S.(3);Kopylov, U.(3);
(1)Tel-HaShomer Sheba Medical Center+ Bar Ilan University, Department of Gastroenterology, Ramat Gan, Israel;(2)Bar Ilan University, Department of Manegment, Ramat Gan, Israel;(3)Tel-HaShomer Sheba Medical Center, Department of Gastroenterology, Ramat Gan, Israel;
N06: Assessing stakeholder identified barriers and enablers to Ultrasound implementation for assessment of Crohn's Disease in the UK: A qualitative interview studyECCO'22Year: 2022
Authors: RadfordBSc- MSc- PGCert- PhD student, S.(1);Leighton, P.(2);Coad, J.(3);Moran, G.(1);
(1)Nottingham NIHR Biomedical Research Centre, Liver and Gastrointestinal Disorders Translational Medicine, Nottingham, United Kingdom;(2)The University of Nottingham, Faculty of Medicine, Nottingham, United Kingdom;(3)University of Nottingham, Faculty of Health Sciences, Nottingham, United Kingdom;
N08: The influence of the Covid-19 epidemic on access to medical advice for children with Inflammatory Bowel Disease (IBD), based on patients from The Children's Memorial Health Institute, Warsaw (IPCZD).ECCO'22Year: 2022
Authors: Kotkowicz Szczur, M.(1);Matuszczyk, M.(2);Kierkuś, J.(2);
(1)Instytut Pomnik Centrum Zdrowia Dziecka, Oddział Gastroenterologi- Hepatologii i Zaburzeń Karmienia, Warsaw, Poland;(2)The Children's Memorial Health Institute., Department of Gastroenterology- Hepatology- Feeding disorders and Pediatrics, Warsaw, Poland;
N09: Disease knowledge and quality of life perception in Inflammatory Bowel Disease: a randomised controlled trialECCO'22Year: 2022
Authors: MartinatoRN PhD, M.(1);Comoretto, R.I.(2);Monaco, E.(1);Ocagli, H.(1);Gregori, D.(1);
(1)University of Padova, Department of Cardiac- Thoracic- Vascular Sciences and Public Health, Padova, Italy;(2)University of Torino, Department of Public Health and Pediatric, Torino, Italy;
N11: Development of a young person clinic for 16-24-year-olds with Inflammatory Bowel Disease (IBD), using a multidisciplinary team (MDT) approach.ECCO'22Year: 2022
Authors: Hamzawi, M.(1);Hickey, Y.(1);Brannick, S.(1);Brett Kilmurray, O.(1);Jones, F.(1);Sheridan, J.(1);Cullen, G.(1);
(1)St Vincent's University Hospital, Department of Gastroenterology, Dublin, Ireland;
N12: Systematic Review: The role of psychological stress in Inflammatory Bowel DiseaseECCO'22Year: 2022
Authors: Black, J.(1);Sweeney, L.(1);Yuan, Y.(1);Singh, H.(2);Norton, C.(1);Czuber-Dochan, W.(1);
(1)King's College London, Florence Nightingale Faculty of Nursing- Midwifery & Palliative Care, London, United Kingdom;(2)Study Advisory Group, n/a, London, United Kingdom;
N13: Clinical service delivery implications of the Covid-19 pandemic on people with inflammatory bowel disease: a qualitative studyECCO'22Year: 2022
Authors: Kemp, K.(1);Avery, P.(2);Bryant, R.(3);Cross, A.(4);Danter, K.(3);Kneebone, A.(5);Morris, D.(6);Walker, A.(7);Whitley, L.(8);Dibley, L.(9);
(1)Manchester Royal Infirmary, Gastroenterology, Manchester, United Kingdom;(2)St Mark's Hospital- Harrow, IBD Unit, London, United Kingdom;(3)Patient and Public Involvement Colleague, x, x, United Kingdom;(4)Gloucestershire Hospitals NHS Foundation Trust, Gastroenterology, Gloucester, United Kingdom;(5)Royal Bolton Hospital, Gastroenterology, Bolton, United Kingdom;(6)Lister Hospital, Endoscopy, Stevenage, United Kingdom;(7)South Warwickshire NHS Foundation Trust, Gastroenterology, Warwick, United Kingdom;(8)University College London Hospitals NHS Foundation Trust, Gastroenterology, London, United Kingdom;(9)University of Greenwich, Faculty of Education- Health and Human Sciences, London, United Kingdom;
N14: Who can do it, if not me? - Identification of biopsychosocial predictors for the quality of life, satisfaction with life, and acceptance of the gastrointestinal diseaseECCO'22Year: 2022
Authors: Rudnik, A.(1);Piotrowicz, G.(2);Piotrowicz, A.(3);Bidzan, M.(4);Rydzewska, G.(5);
(1)University of Gdansk, Institute of Psychology, Gdańsk, Poland;(2)Independent Public Health Care of the Ministry of the Internal Affairs, Department of Gastroenterology-, Gdańsk, Poland;(3)Independent Public Health Care of the Ministry of the Internal Affairs, Department of Gastroenterology, Gdańsk, Poland;(4)University of Gdańsk, Institute of Psychology, Gdańsk, Poland;(5)Central Clinical Hospital of the Ministry of the Interior and Administration in Warsaw, Department of Internal Medicine and Gastroenterology with Inflammatory Bowel Disease Subdivision, Warsaw, Poland;
N15: Feedback from adolescents and parents on the transition process to an Irish Adult IBD serviceECCO'22Year: 2022
Authors: Hamzawi, M.(1);Brannick, S.(1);Hickey, Y.(1);Jones, F.(1);Brett Kilmurray, O.(1);Sheridan, J.(1);Cullen, G.(1);
(1)St Vincent's University Hospital, Department of Gastroenterology, Dublin, Ireland;
N16: ‘Same storm, different boat’… Exploring the impact of the COVID-19 pandemic on patients with Inflammatory Bowel Disease, with or without shielding: a qualitative studyECCO'22Year: 2022
Authors: Kemp, K.(1);Avery, P.(2);Bryant, R.(3);Cross, A.(4);Danter, K.(3);Kneebone, A.(5);Morris, D.(6);Walker, A.(7);Whitley, L.(8);Dibley, L.(9);
(1)Manchester Royal Infirmary, Department of Gastroenterology, Manchester, United Kingdom;(2)St. Mark's Hospital, IBD Unit, London, United Kingdom;(3)Patient & Public Involvement Colleague, x, x, United Kingdom;(4)Gloucestershire Hospitals NHS Foundation Trust, Gastroenterology, Gloucester, United Kingdom;(5)Royal Bolton Hospital, Gastroenterology, Bolton, United Kingdom;(6)Lister Hospital, Endoscopy, Stevenage, United Kingdom;(7)South Warwickshire NHS Foundation Trust, Gastroenterology, Warwick, United Kingdom;(8)University College London Hospitals NHS Foundation Trust, Gastroenterology, London, United Kingdom;(9)University of Greenwich, Faculty of Education- Health and Human Sciences, London, United Kingdom;
N17: Co Design of young person’s IBD clinic for 16-24 year oldsECCO'22Year: 2022
Authors: Hamzawi, M.(1);Brannick, S.(2);Hickey, Y.(2);Cullen, G.(2);Sheridan, J.(2);
(1)St Vincent's University Hospital, Department of Gastroenterology, Dublin, Ireland;(2)St Vincent's University Hospital, Gastroenterology, Dublin, Ireland;
N18: Introduction of inflammatory bowel disease specialized dietitian and nutritional status in a multidisciplinary IBD teamECCO'22Year: 2022
Authors: Hoekx, S.(1);Vanderstappen, J.(1);Wellens, J.(1);Verstockt, B.(1);Marc, F.(1);Vermeire, S.(1);Guedelha Sabino, J.(1);
(1)KU Leuven, Gastroenterology, Leuven, Belgium;
N19: Improving the standard of care for patients with IBD - translating the N-ECCO Consensus StatementsECCO'22Year: 2022
Authors: Kjaer-Mikkelsen, E.(1);Hindhede, A.(2);Bager, P.(3);
(1)Regional Hospital West Jutland, Unit of Gastroenterology, Herning, Denmark;(2)Odense University Hospital, Medical Gastrointestinal Diseases, Odense, Denmark;(3)Aarhus University Hospital, Department of Hepatology and Gastroenterology, Aarhus N, Denmark;
OP01: Withdrawal of infliximab or anti-metabolite therapy in Crohn’s Disease patients in sustained remission on combination therapy: A randomized unblinded controlled trial (SPARE)ECCO'22Year: 2022
Authors: LouisJ, E.(1);Resche-Rigon, M.(2);Laharie, D.(3);Satsangi, J.(4);Ding, N.(5);Preiss, J.(6);d'haens, G.(7);picon, L.(8);bossuyt, P.(9);vuitton, L.(10);irving, P.(11);bouhnik, Y.(12);viennot, S.(13);lamb, C.(14);pollock, R.(15);baert, F.(16);nachury, M.(17);mathurin, F.(18);Gilletta, C.(19);colombel, J.F.(20);hertervig, E.(21);
(1)CHU Liège- Sart Tilman, Department of Gastroenterology, Liège, Belgium;(2)Inserm U1077, Biostatistics, Paris, France;(3)CHU Bordeaux, Gastroenterology, Bordeaux, France;(4)John Radcliffe hospital, Gastroenterology, Oxford, United Kingdom;(5)St Vincent Hospital Melbourne, Gastrtoenterology, Melbourne, Australia;(6)Charite Berlin, Gastroenterology, Berlin, Germany;(7)AMC Amsterdam, Gastroenterology, Amsterdam, The Netherlands;(8)CHU Tours, Gastroenterology, Tours, France;(9)Imelda Hospital, Gastroenterology, Bonheiden, Belgium;(10)CHU Besancon, Gastroenterology, Besancon, France;(11)London-Guy's and Thomas, Gastroenterology, London, United Kingdom;(12)Hôpital Beaujon, Gastroenterology, Paris, France;(13)CHU Caen, Gastroenterology, Caen, France;(14)Royal Victoria Infirmary, Gastroenterology, Newcastle, United Kingdom;(15)St Georges' University Hospital, Gastroenterology, London, United Kingdom;(16)AZ Delta, Gastroenterology, Roeselare, Belgium;(17)CHU Lille, Gastroenterology, Lille, France;(18)CHU Amiens, Gastroenterology, Amiens, France;(19)CHU Toulouse, Gastroenterology, Toulouse, France;(20)Mount Sinai Hopsital, Gastroenterolgy, New York, United States;(21)skane university hospital, gastroenterology, Lund, Sweden;
OP02: The breastmilk proteomics of women with Inflammatory Bowel Disease (IBD) and its impact on fecal calprotectin and microbiota composition in their babiesECCO'22Year: 2022
Authors: Guedelha Sabino, J.(1);Tarassishin, L.(2);Agrawal, M.(3);Eisele, C.(2);Barré, A.(2);Dubinsky, M.(4);Stone, J.(5);Nair, N.(2);Debebe, A.(2);Hawkins, K.(2);Rendon, A.(2);Hu, J.(2);Colombel, J.F.(3);Peter, I.(2);Torres, J.(6);
(1)KU Leuven, Gastroenterology, Leuven, Belgium;(2)Icahn School of Medicine at Mount Sinai, Department of Genetics and Genomic Sciences, New York, United States;(3)Icahn School of Medicine at Mount Sinai-, Division of Gastroenterology- Department of Medicine, New York, United States;(4)Icahn School of Medicine at Mount Sinai, Division of Pediatric Gastroenterology and Hepatology, New York, United States;(5)Icahn School of Medicine at Mount Sinai, Department of Obstetrics- Gynecology and Reproductive Sciences-, New York, United States;(6)Hospital Beatriz Ângelo, Gastroenterology Division, Loures, Portugal;
OP03: Standardized faecal microbiota transplantation with microbiome-guided donor selection in active UC patients: A randomized, placebo-controlled intervention studyECCO'22Year: 2022
Authors: Caenepeel, C.(1,2);Deleu, S.(1);Arnauts, K.(1);Vazquez Castellanos, J.F.(3);Braekeleire, S.(1);Machiels, K.(1);Baert, F.(4);Mana, F.(5);Pouillon, L.(6);Hindryckx, P.(7);Lobaton, T.(7);Louis, E.(8);Franchimont, D.(9);Ferrante, M.(1,2);Sabino, J.(1,2);Vieira-Silva, S.(3);Falony, G.(3);Raes, J.(3);Vermeire, S.(1,2);
(1)KU Leuven, TARGID - Department of chronic diseases and metabolism, Leuven, Belgium;(2)University Hospitals Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium;(3)Rega institute, Department of Microbiology and Immunology, Leuven, Belgium;(4)AZ Delta Roeselare, Department of Gastroenterology and Hepatology, Roeselare, Belgium;(5)University Hospitals Brussel, Department of Gastroenterology and Hepatology, Brussel, Belgium;(6)Imelda Hospital Bonheiden, Department of Gastroenterology and Hepatology, Leuven, Belgium;(7)Ghent University Hospital, Department of Gastroenterology and Hepatology, Ghent, Belgium;(8)CHU Liège, Department of Gastroenterology and Hepatology, Liège, Belgium;(9)Erasmus Hospital Brussel, Department of Gastroenterology and Hepatology, Brussel, Belgium;
